|
Platelet function inhibitors
Citations 1-10 of 42 total displayed.
|
Most recent content
(1 Jul 2008):
|
- Cochrane Corner
Antiplatelet Therapy in Aneurysmal Subarachnoid Hemorrhage
- Sanne M. Dorhout Mees, Walter M. van den Bergh, Ale Algra, and Gabriel J.E. Rinkel
Stroke 39: 2186 -2187; published online before print as doi:10.1161/STROKEAHA.107.509257
[Full text]
|
Past content
(since Jan 2002):
|
- Original Contributions
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)
- Jeff S. Healey, Robert G. Hart, Janice Pogue, Marc A. Pfeffer, Stefan H. Hohnloser, Raffaele De Caterina, Greg Flaker, Salim Yusuf, and Stuart J. Connolly
Stroke 39: 1482 -1486; published online before print as doi:10.1161/STROKEAHA.107.500199
[Abstract]
[Full text]
- Cochrane Corner
Dipyridamole for Preventing Stroke and Other Vascular Events in Patients With Vascular Disease: An Update
- Els L.L.M. De Schryver, Ale Algra, and Jan van Gijn
Stroke 39: 1397 -1398; published online before print as doi:10.1161/STROKEAHA.107.499723
[Full text]
- Cochrane Corner
Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks
- Maria I. Aguilar and Robert Hart
Stroke 39: 1399 -1400; published online before print as doi:10.1161/STROKEAHA.107.500363
[Full text]
- Articles
Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks
- Maria I. Aguilar and Robert Hart
Stroke published March 6, 2008, doi:10.1161/STROKEAHA.107.500363
[Abstract]
- Articles
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk. The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)
- Jeff S. Healey, Robert G. Hart, Janice Pogue, Marc A. Pfeffer, Stefan H. Hohnloser, Raffaele De Caterina, Greg Flaker, Salim Yusuf, and Stuart J. Connolly
Stroke published March 6, 2008, doi:10.1161/STROKEAHA.107.500199
[Abstract]
- Articles
Dipyridamole for Preventing Stroke and Other Vascular Events in Patients With Vascular Disease. An Update
- Els L.L.M. De Schryver, Ale Algra, and Jan van Gijn
Stroke published February 14, 2008, doi:10.1161/STROKEAHA.107.499723
[Abstract]
- Original Contributions
Randomized Controlled Trial of Acetylsalicylic Acid in Aneurysmal Subarachnoid Hemorrhage: The MASH Study
- Walter M. van den Bergh on behalf of the MASH Study Group
Stroke 37: 2326 -2330; published online before print as doi:10.1161/01.STR.0000236841.16055.0f
[Abstract]
[Full text]
- Articles
Randomized Controlled Trial of Acetylsalicylic Acid in Aneurysmal Subarachnoid Hemorrhage. The MASH Study
- Walter M. van den Bergh on behalf of the MASH Study Group
Stroke published August 3, 2006, doi:10.1161/01.STR.0000236841.16055.0f
[Abstract]
- Original Contributions
Effect of Enteric Coating on Antiplatelet Activity of Low-Dose Aspirin in Healthy Volunteers
- Dermot Cox, Andrew O. Maree, Michelle Dooley, Ronán Conroy, Michael F. Byrne, and Desmond J. Fitzgerald
Stroke 37: 2153 -2158; published online before print as doi:10.1161/01.STR.0000231683.43347.ec
[Abstract]
[Full text]
|
|
